Health Technology Assessment In China: a friend in need?
This article was originally published in Scrip
Executive Summary
China is increasingly turning to health technology assessment (HTA) for medical cost containment, but the tool can't be used alone, Peking University health economist Gordon Liu has pointed out. Surprisingly, more domestic drug makers are adopting pharmacoeconomics (PE) approaches, citing nothing to lose.